Derriston Capital PLC Director Declaration (6302A)
March 27 2017 - 6:18AM
UK Regulatory
TIDMDERR
RNS Number : 6302A
Derriston Capital PLC
27 March 2017
Derriston Capital plc
Director Declaration
Derriston Capital plc, which has been created to consider
opportunities within the global medical technology industry,
announces that Harry Hyman, non-executive Chairman, is a
non-executive Director of BioPharma Credit plc, which began trading
on the London Stock Exchange this morning.
For information please contact:
Walbrook PR Ltd Tel: 020 7933 8780
Paul McManus lifesciences@walbrookpr.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNMMGZFMNVGNZM
(END) Dow Jones Newswires
March 27, 2017 07:18 ET (11:18 GMT)
Derriston Cap. (LSE:DERR)
Historical Stock Chart
From Apr 2024 to May 2024
Derriston Cap. (LSE:DERR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Derriston Cap. (London Stock Exchange): 0 recent articles
More Derriston Cap. News Articles